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Mycoplasma synoviae is a Gram positive bacteria lacking of cell wall that aﬀects chickens and turkeys causing infection in the
upper respiratory tract and in some cases arthritis, with economical impact to broiler breeders. Treatment and prevention of
avian synovitis depend on knowledge of the infectious process. Secreted or surface-exposed proteins play a critical role in disease
because they oftenmediate interactions between host and pathogen. In the present work, we sought to identify possibleM. synoviae
secreted proteins by cultivating the bacteria in a modified protein-free Frey medium. Using this approach, we were able to detect
in the cell-free fraction a number of proteins that have been shown in other organisms to be secreted, suggesting that they may
also be secreted by M. synoviae.
1. Introduction
The growth of poultry industry is often limited by infectious
diseases that aﬀect birds. Mycoplasma synoviae is a major
avian extracellular pathogen associated with synovitis in
chickens and turkeys [1, 2]. Disease can occur as chronical
subclinical to severe upper respiratory infection and, under
unknown conditions, become systemic and cause arthritis
[3]. The disease causes economic losses by retarding growth
and downgrading at slaughter [3]. Strategies to control
this pathogen rely mainly in better management practices,
improvement in housing conditions and antibiotic usage,
whereas an eﬀective vaccine is still not available [4].
Secreted proteins of pathogenic bacteria are key factors
in host colonization. The analysis of these proteins, called
secretome, can therefore permit the identification of new
putative virulence factors that are fundamental for host
invasion and survival in the environment within the host
[5]. In this context, two-dimensional electrophoresis (2DE)
along with peptide fingerprinting by mass spectrometry
(MS) and subsequent protein identification have become
a powerful method to unravel pathogenicity factors in
microorganisms [6, 7].
We have recently reported a proteomic analysis of M.
synoviae cell extracts in conventional Freymedium [8]. In the
present work, we have grown M. synoviae in the same typical
culture medium and then incubated the cells in a protein-
free modified Frey medium as a strategy to indicate proteins
that can be secreted to the medium by the bacteria.
2. Methods
2.1. Mycoplasma synoviae Cultures. M. synoviae strain 53
isolated from a broiler breeder was grown in the Laboratory
of Genetics and Animal Health from EMBRAPA Swine
and Poultry (Conco´rdia, C, Brazil) as described by Frey
and coworkers (1968). The cells were cultured in Frey
broth [9] supplemented with 12% swine serum, 0.1 g/L
nicotinamide adenine dinucleotide (NAD), 0.1 g/L cysteine
hydrochloride hydrate, 106 IU penicillin G, and 0.25 g/L
thallium acetate at 37◦C until the culture reached mid-
log phase as indicated by color change and turbidity. Cells
were pelleted by centrifugation and washed three times
with “protein-free” modified Frey broth (3 g/L glucose,
0.1 g/L NAD, 0.1 g/L cysteine hydrochloride hydrate, 106
IU penicillin G, and 0.25 g/L thallium acetate) to reduce
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the level of contaminant proteins present in the growth
medium.
Cells were cultured in this protein-free medium for 48 h
and then centrifuged. Cell pellets were stored at −80◦C and
supernatants at −20◦C. In order to assess the presence of
contaminant proteins, equal volumes of protein-free Frey
broth not exposed to M. synoviae cells were concentrated
and analysed by two-dimensional gel electrophoresis (2DE)
as described below.
2.2. Medium Concentration and Protein Extraction. Samples
of 500 mL of protein-free Frey broth inoculated with M. syn-
oviae were concentrated to 50 ml in a Quix Stand Benchtop
concentrator through a GE Healthcare Xampler UFP-10-C-
4X2MA membrane, 10,000 NMWC cutoﬀ. Trichloroacetic
acid (TCA) was added to a final concentration of 12% and
samples were allowed to precipitate for at least 1 h on ice.
Proteins were then pelleted by centrifugation at 16,000 x g for
20min at 4◦C and pellets were washed three times with cold
acetone (−20◦C). Samples were then airdried and solubilized
in rehydration solution containing 7M urea, 2 M thiourea,
4% CHAPS, 0.5% IPG buﬀer, pH 3–10, 18mM dithiothre-
itol (DTT), and 0.002% bromophenol blue. Total protein
concentration was determined using the 2-D Quant Kit (GE
Healthcare) according to the manufacturer’s instructions.
2.3. Two-Dimensional Electrophoresis. Samples in rehydra-
tion solution (250 μg of total proteins) were applied on
13 cm long GE Immobiline DryStrip Gels (Ge Healthcare,
Uppsala, Sweden), pH 3–10, and kept overnight at room
temperature prior to isoelectric focusing (IEF). IEF was
performed using the Ettan IPGphor 3 system (GeHealthcare,
Uppsala, Sweden) with maximum temperature set to 20◦C
with a total voltage of 17 kVh (500V for 1 h, 500V to 1000V
gradient in 1 h, 1000V to 8000V gradient in 2 hours 30 min,
8000 V for 30 min) and maximum current set at 25 μA/strip.
After IEF, strips were equilibrated for 20min in 6M urea,
30% glycerol, 2% SDS, 50 mM Tris-HCl, pH 8.8 containing
1%DTT, and another 20min in the same solution containing
4% iodoacetamide instead of DTT. Equilibration treatments
were performed under gentle shaking at room temperature.
Second dimension was run in homogeneous 12% acrylamide
gels. The gels were then fixed in 8% phosphoric acid and
40% ethanol and stained with Colloidal Coomassie Brilliant
Blue G-250 (Bio-Rad, Hercules, USfA). The stained gels
were scanned in a GE Healthcare ImageScanner III and
images were analysed with the GE Healthcare ImageMaster
2D Platinum 7.2 software, having their molecular mass and
isoelectric point calculated. Spots were excised manually and
kept in 0.5% acetic acid.
2.4. In-Gel Digestion, Mass Spectrometry Analysis, and Protein
Identification. Gel plugs were washed three times in 25mM
ammonium bicarbonate in 50% acetonitrile for destaining
and dehydrated in 100% acetonitrile. Dry plugs were rehy-
drated with trypsin solution (10 μg/mL Promega Trypsin
Gold Mass Spectrometry Grade in 25mM ammonium
bicarbonate) and incubated for 12 to 16 h at 37◦C. Peptides
were extracted from gel plugs by three successive washes
with 50% acetonitrile, 5% trifluoroacetic acid (TFA) for
30min per wash and combined peptide extracts were dried
in a vacuum concentrator (Eppendorf VacuumConcentrator
Plus). Peptides were resuspended in 0.1% TFA and mixed
with equal volume of matrix solution (10mg/mL α-cyano-
4-hydroxycinnamic acid in 0,1% TFA in 1 : 1 acetoni-
trile/methanol), applied on the MALDI target plate, and
allowed to crystallize at room temperature.Mass spectra were
obtained in a mass range of 400 to 4,300 Da using a laser
(337 nm, 200Hz) as the ionization source. Each spectrum
was formed by accumulated data from at least 900 shots,
using the Bruker Daltonics flexControl 3.3 program. The
instrument (Autoflex IIIMALDI-TOF Bruker Daltonics) was
used in reflectron positive mode with an acceleration voltage
of 19 kV. As external calibrant a Bruker Daltonics mix con-
taining angiotensin II, angiotensin I, substance P, bombesin,
ACTH Chip 1-17, ACTH Chip 18-39, and somatostatin
28, was used. Matrix and autolytic peaks of trypsin were
used as internal calibration standards. Peptide lists were
compared to the NCBInr database, using MASCOT search
engine (http://www.matrixscience.com/). Search parameters
were set as follows: enzyme: trypsin; taxon: Mycoplasma;
fixed modifications: cysteine carbamidomethylation; vari-
able modifications: methionine oxidation; mass tolerance:
100 ppm; monoisotopic spectra; 1+ charged masses, decoy
enabled. MASCOT score was the main confidence factor
for protein identification being also considered data of
theoretical and obtained molecular weight and isoelectric
point values, number of peptide matches, and the percentage
of the total translated ORF sequence coverage by the
peptides.
3. Results and Discussion
After 48 h of incubation in a protein-free Frey modified
broth, protein extraction from cell pellets yielded the
identification of 27 protein species, 8 of which were not
detected previously from cell extracts of Mycoplasma syn-
oviae cultivated in conventional Frey broth conditions [8].
These proteins are 6-phosphofructokinase, endopeptidase
O, glucose-6-phosphate isomerase, leucyl aminopeptidase,
phosphoenolpyruvate-protein phosphatase, serine/threo
nine protein kinase, transcription elongation factor GreA,
and XAA-Pro aminopeptidase.
In the extracellular fraction we have identified 3 unchar-
acterized proteins and 16 diﬀerent characterized proteins
(Figure 1 and Table 1), eight of which were not present in the
cell fraction (Table 2), where their presence may have been
masked by the presence of more prominent protein species.
These proteins are cell division protein, DNA polymerase
III beta subunit, elongation factor G, fructose-bisphosphate
aldolase, and hypothetical proteins MS53 0566, MS53 0115,
and MS53 0598.
Acetate kinase and acyl carrier protein phosphodiesterase
cause immunogenic responses in cattle infected by M.
mycoides andM. bovis, respectively [10, 11]. As these proteins
are able to promote an immune response in their hosts, it
seems that they may be secreted or surface exposed during
the infectious process.
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Table 1: Cellular proteins identified in Mycoplasma synoviae.
Identity gi entry
MASCOT Observed Theoretical
Score MW pI MW pI
6-phosphofructokinase gi|144575058 96 33747 9.24 33891 8.67
Acetate kinase gi|144575215 120 37945 7.61 44515 7.10
Acyl carrier protein phosphodiesterase gi|71894112 96 13718 8.42 22687 7.74
Cell division protein gi|71894355 106 70988 3.51 62539 4.38
Elongation factor EF-Ts gi|71894429 91 31657 5.87 31938 5.72
Elongation factor Tu gi|71894677 126 39239 5.50 43230 5.61
Endopeptidase O gi|71894512 162 64809 7.21 42295 6.08
F0F1 ATP synthase subunit beta gi|71894420 89 47222 6.01 50804 5.76
Glucose-6-phosphate isomerase gi|71894495 65 44765 7.56 48990 6.99
Hypothetical protein MS53 0316 gi|71894332 68 73092 4.86 81668 5.48
Leucyl aminopeptidase gi|71894176 151 47812 5.65 52277 5.83
Molecular chaperone DnaK gi|71894366 115 54392 5.37 65096 5.17
Phosphoenolpyruvate-protein phosphatase gi|71894534 103 58361 5.23 63753 5.19
Phosphopyruvate hydratase gi|71894034 108 45607 7.20 63753 5.19
Phosphotransacetylase gi|71894663 98 34133 6.46 35000 6.06
Putative lipoprotein gi|144574996 124 92020 4.96 100677 5.13
Putative lipoprotein gi|71894364 103 96688 5.71 112804 5.94
Putative lipoprotein gi|71894528 66 81447 5.73 85199 5.72
Putative trigger factor gi|71894613 126 55239 5.26 53932 5.31
Pyruvate dehydrogenase E1 component, beta subunit gi|144575045 126 30000 7.41 35853 6.73
Ribonucleotide-diphosphate reductase subunit beta gi|71894414 153 34317 6.10 39239 5.09
Serine/threonine protein kinase gi|47459394 77 37945 6.15 37008 9.35
Single stranded binding protein gi|71894544 155 15419 4.29 21239 4.50
Thiol peroxidase gi|71894383 125 8897 5.45 18263 5.93
Thioredoxin reductase gi|71894606 107 32559 6.32 27439 5.37
Transcription elongation factor GreA gi|71894394 66 8597 4.69 17916 4.95
XAA-Pro aminopeptidase gi|71894172 78 37710 6.73 40194 6.12
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Figure 1: Two-dimensional gel electrophoresis profile of extracellu-
lar fraction of culture media incubated with Mycoplasma synoviae.
Numbered arrows correspond to protein identities listed in Table 2.
Thioredoxin reductase was described as surface exposed
in Trichomonas vaginalis, and the authors suggest that they
may change host mucus viscosity by modifying disulphide
bonds [12].
Fructose-bisphosphate aldolase, which is surface exposed
in Enterococcus faecalis [13], is immunogenic to cattle
infected with M. mycoides [10].
Both subunits alpha and beta of pyruvate dehydroge-
nase component E1 from bacilli and mycoplasmas show
immunogenicity [10, 14, 15], and the subunit alpha of this
complex was shown to be surface-exposed in M. genitalium
[14]. Moreover, both subunits alpha and beta have increased
expression inM. pulmonis clones resistant to gentamicin and
melittin [16].
Elongation factor G, which is secreted by Paenibacil-
lus larvae [17] is produced by Bacillus anthracis and B.
thuringiensis and are immunogenic to their hosts [15], as it
happens in cattle infected by M. bovis [11] and M. mycoides
[18] and chickens infected by M. synoviae [18].
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Table 2: Proteins present in the extracellular fraction of culture media incubated with Mycoplasma synoviae.
Identity gi entry
MASCOT Observed Theoretical
Score MW pI MW pI
(1) Cell division protein gi|144575078 97 77515 3.66 62539 4.38
(2) Elongation factor G gi|71894071 79 72218 5.25 77259 5.28
(3) Molecular chaperone DnaK gi|71894366 61 63596 3.51 65096 5.17
(4) Cell division protein gi|71894355 120 79326 3.49 62539 4.38
(5) Elongation factor Tu gi|71894677 111 37523 5.43 43230 5.61
(6) Phosphopyruvate hydratase gi|71894034 62 43611 6.01 49330 6.59
(7) Ribonucleotide-diphosphate reductase subunit beta gi|71894414 127 34255 3.88 39239 5.09
(8) Phosphotransacetylase gi|71894663 169 34605 4.94 35000 6.06
(9) Pyruvate dehydrogenase E1 component, alpha subunit gi|71894294 68 36239 5.87 42131 6.20
(10) Acetate kinase gi|144575215 80 36194 6.10 44515 7.10
(11) DNA polymerase III beta subunit gi|71894027 104 38563 6.96 43399 7.62
(12) Thioredoxin reductase gi|144575189 110 31039 4.67 27439 5.37
(13) Pyruvate dehydrogenase E1 component, beta subunit gi|144575045 224 32423 6.12 35853 6.73
(14) Fructose-bisphosphate aldolase gi|71894369 76 26539 5.82 31237 6.27
(15) Single stranded binding protein gi|71894544 88 14149 3.00 21239 4.50
(16) Acyl carrier protein phosphodiesterase gi|71894112 94 13164 7.29 22687 7.74
(17) Hypothetical protein MS53 0566 gi|144575177 90 10711 3.36 20869 4.96
(18) Hypothetical protein MS 53 0115 gi|71894139 103 18926 8.23 21059 8.77
(19) Hypothetical protein MS 53 0598 gi|71894608 97 42120 4.67 44307 5.60
EF-Tu has expression upregulated in the highly adhe-
sive strain Lactobacillus plantarum WHE92 [19] and was
demonstrated as extracellular in Mycobacterium tuberculosis,
with capacity to bind to human plasminogen [20]. It is
also secreted by B. anthracis, B. cereus, and B. thuringiensis
with immunogenic eﬀects [15, 21]. About 17% of total M.
pneumoniae EF-Tu is associated with the membrane [22],
being also demonstrated on the surface of M. genitalium and
M. pneumoniae [14, 23]. It is immunogenic to mice infected
with M. genitalium [14], to cattle infected with M. mycoides
[10], to pigs infected with M. hyopneumoniae [24], and to
chickens infected with M. synoviae [18].
As it happens to EF-Tu, the molecular chaperone DnaK
shows upregulation in the highly adhesive strain of L.
plantarum WHE 92 [19]. It was also observed on the
surface of E. faecalis, along with fructose-bisphosphate
aldolase [13], and in M. tuberculosis it has been demon-
strated as extracellular, immunogenic, and capable to bind
to human plasminogen [20, 25, 26]. B. anthracis DnaK
is secreted, immunogenic and seems to act as virulence
factor [21]. These evidences suggest that the chaperone
DnaK is secreted by a number of pathogens and may be
important in the disease process by mediating adhesion
to host tissues. Pigs infected with M. hyopneumoniae [24],
cattle with M. mycoides [10] and M. bovis [11], mice with
M. genitalium [14], and chickens infected with M. synoviae
[18] all rise antibodies against the molecular chaperone
DnaK.
Finally, enolase is an enzyme widely described as secreted
or surface exposed in several microorganisms of the genera
Paenibacillus, Bacillus, Lactobacillus, and Streptococcus [17,
27–30], showing immunogenic properties [15, 21, 29] and
ability to bind to fibronectin [30, 31]. Enolase is also shown
to be a virulence factor in P. larvae [32] and is found on the
surface of L. crispatus in a pH-dependent way, being released
to the medium at pH close to its isoelectric point or more
alkaline [28]. In Mycoplasmas it has been detected on the
surface of M. gallisepticum and M. fermentans, in both cases
able to bind to plasminogen [33, 34]. InM. suis its role in cell
adhesion was clearly demonstrated by inserting the gene in
Escherichia coli that once transformed became able to bind
to swine red blood cells [35].
4. Concluding Remarks
We conclude that by incubating M. synoviae cells in protein-
free modified Frey medium we were able to produce clearly
diﬀerent gel profiles using protein extracts from the cellular
and extracellular fractions, showing exclusive proteins for
each fraction. In the extracellular fraction we have found
proteins that are originally described as cytosolic but in more
recent studies are shown in other pathogenic microorgan-
isms to be either surface exposed or secreted, immunogenic
or able to bind host components as fibronectin or plas-
minogen, thus participating in the infectious process. These
proteins are acetate kinase, elongation factor G, elongation
factor Tu, acyl carrier protein phosphodiesterase, fructose
bisphosphate aldolase, thioredoxin reductase, DnaK, both
alpha and beta units of pyruvate dehydrogenase E1 compo-
nent, and enolase. These evidences suggest that they may be
secreted byM. synoviae and can thus be implicated in disease
process.
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